Wood W.-J., Vargas X., Schwartz G., Dongier M. (2001). À propos de la guérison naturelle, de l'effet dit placebo et des études psychopharmacologiques dans le traitement de l'alcoolisme . In Brochu S., Guyon. L. , Landry M. & Brochu S. (Eds.) , Impact du traitement en alcoolisme et toxicomanie : études québécoises (pp. 173-187). Presses de l'Université Laval.

Xu Y. C., Johnson K. W., Phebus L. A., Cohen M., Nelson D. L., Schenck K., Walker C., Fritz J. E., Kaldor S. W., LeTourneau M. E., Murff R. E., Zgombick J. M., Calligaro D. O., Audia J. E., Schaus J. M. (2001). N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy, J Med Chem, 44(24), 4031-4.

Yamamoto K., Bloom D., La S., Turecki G., Joober R., Benkelfat C., Lalonde P., Labelle A., Rouleau G. A. (2001). Polymorphism in the cell division cycle 45 like gene and schizophrenia, Am J Med Genet, 105(2), 214-5.

Zhou L., Rowley D. L., Mi Q. S., Sefcovic N., Matthes H. W., Kieffer B., Donovan D. M. (2001). Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells, Mamm Genome, 12(10), 772-8. Find out more.

Bigoni R., Rizzi A., Rizzi D., Becker J. A., Kieffer B., Simonin F., Regoli D., Calo G. (2000). In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors, Life Sci, 68(2), 233-9. Find out more.

Filliol D., Ghozland S., Chluba J., Martin M., Matthes H. W., Simonin F., Befort K., Gaveriaux-Ruff C., Dierich A., LeMeur M., Valverde O., Maldonado R., Kieffer B. (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses, Nat Genet, 25(2), 195-200. Find out more.

Fleck M. P., Louzada S., Xavier M., Chachamovich E., Vieira G., Santos L., Pinzon V. (2000). [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref], Rev Saude Publica, 34(2), 178-83. Find out more.

Kieffer B. (2000). Opioid receptors: from genes to mice, J Pain, 1(3 Suppl), 45-50. Find out more.

Monory K., Bourin M. C., Spetea M., Tomboly C., Toth G., Matthes H. W., Kieffer B., Hanoune J., Borsodi A. (2000). Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2, Eur J Neurosci, 12(2), 577-84. Find out more.

Roberts A. J., McDonald J. S., Heyser C. J., Kieffer B., Matthes H. W., Koob G. F., Gold L. H. (2000). mu-Opioid receptor knockout mice do not self-administer alcohol, J Pharmacol Exp Ther, 293(3), 1002-8. Find out more.

Fleck M. P., Louzada S., Xavier M., Chachamovich E., Vieira G., Santos L., Pinzon V. (1999). [Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)], Rev Saude Publica, 33(2), 198-205. Find out more.